心肌梗死患者中与房颤相关的死亡风险
Mortality Risk Associated with AF in Myocardial Infarction Patients.
作者信息
Sankaranarayanan Rajiv
机构信息
Cardiology Specialist Registrar in Electrophysiology and British Heart Foundation Clinical Research Fellow Manchester Heart Centre (Manchester Royal Infirmary) and University of Manchester, Cardiovascular Research Group, 3rd Floor, Core Technology Facility, 46, Grafton Street, Manchester M13 9PL, United Kingdom.
出版信息
J Atr Fibrillation. 2012 Oct 6;5(3):554. eCollection 2012 Oct-Nov.
Abstract
Atrial fibrillation (AF) complicating myocardial infarction (MI) has been a controversial topic for the last few decades. It has generated a plethora of debates regarding whether it is a risk indicator of co-morbidities and poor haemodynamic status or independent causal mediator of poor outcomes. The management of this condition has also been idiosyncratic probably due to confusion regarding its prognostic significance. We shall review the literature and attempt to elucidate the prognostic significance as well as evidence available for defining management strategies.
摘要
在过去几十年里，心房颤动（AF）合并心肌梗死（MI）一直是一个备受争议的话题。关于它是合并症和血流动力学状态不佳的风险指标，还是不良结局的独立因果介导因素，引发了大量争论。由于对其预后意义存在困惑，这种情况的管理也一直很特殊。我们将回顾文献，并试图阐明其预后意义以及可用于确定管理策略的证据。
相似文献
1
Mortality Risk Associated with AF in Myocardial Infarction Patients.
J Atr Fibrillation. 2012 Oct 6;5(3):554. eCollection 2012 Oct-Nov.
2
New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction.
Arch Cardiovasc Dis. 2015 Nov;108(11):598-605. doi: 10.1016/j.acvd.2015.06.009. Epub 2015 Oct 29.
3
Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.
Circulation. 2000 Mar 7;101(9):969-74. doi: 10.1161/01.cir.101.9.969.
4
Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke.
Chest. 2007 Jul;132(1):44-9. doi: 10.1378/chest.06-2733. Epub 2007 Mar 30.
5
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
Card Electrophysiol Rev. 2003 Sep;7(3):201-7. doi: 10.1023/B:CEPR.0000012382.81986.47.
6
Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis.
Sci Rep. 2017 Jun 13;7(1):3360. doi: 10.1038/s41598-017-03653-5.
7
[Atrial fibrillation during myocardial infarction with and without ST segment elevation].
Arch Mal Coeur Vaiss. 2005 Jun;98(6):608-14.
8
Impact of Atrial Fibrillation On Cardiovascular Mortality in the Setting of Myocardial Infarction.
J Atr Fibrillation. 2012 Dec 16;5(4):722. doi: 10.4022/jafib.722. eCollection 2012 Dec.
9
Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.
Eur Heart J. 2006 Feb;27(3):290-5. doi: 10.1093/eurheartj/ehi629. Epub 2005 Nov 2.
10
Prognostic Impact of Atrial Fibrillation in Acute Myocardial Infarction and Cardiogenic Shock.
Circ Cardiovasc Interv. 2019 Jun;12(6):e007661. doi: 10.1161/CIRCINTERVENTIONS.118.007661. Epub 2019 Jun 6.
引用本文的文献
1
How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?
Curr Cardiol Rev. 2015;11(3):190-8. doi: 10.2174/1573403x10666140902143020.
本文引用的文献
1
Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.
Am Heart J. 2012 Apr;163(4):720-8. doi: 10.1016/j.ahj.2012.01.017. Epub 2012 Mar 14.
2
Effect of type of atrial fibrillation on prognosis in acute myocardial infarction treated invasively.
Am J Cardiol. 2012 Jun 15;109(12):1689-93. doi: 10.1016/j.amjcard.2012.02.009. Epub 2012 Mar 20.
3
Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance.
Neth Heart J. 2012 Apr;20(4):155-60. doi: 10.1007/s12471-012-0242-5.
4
Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
Am J Cardiol. 2012 Mar 15;109(6):831-8. doi: 10.1016/j.amjcard.2011.10.046. Epub 2011 Dec 22.
5
Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.
Coron Artery Dis. 2012 Jan;23(1):1-8. doi: 10.1097/MCA.0b013e32834df552.
6
Rivaroxaban in patients with a recent acute coronary syndrome.
N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.
7
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7.
8
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).
Eur Heart J. 2011 Dec;32(23):2999-3054. doi: 10.1093/eurheartj/ehr236. Epub 2011 Aug 26.
9
Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
Thromb Haemost. 2011 Nov;106(5):877-84. doi: 10.1160/TH11-05-0343. Epub 2011 Aug 25.
10
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.
Thromb Haemost. 2011 Oct;106(4):572-84. doi: 10.1160/TH11-04-0262. Epub 2011 Jul 25.
Zotero 插件